diallyl trisulfide has been researched along with metallothionein in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, J; Gao, J; Guo, M; Huang, J; Li, W; Lin, B; Lin, S; Lu, Y; Pan, Y; Shen, L; Wang, JM; Xing, R; Zhao, Y; Zhu, M | 1 |
1 other study(ies) available for diallyl trisulfide and metallothionein
| Article | Year |
|---|---|
Epigenetic Upregulation of Metallothionein 2A by Diallyl Trisulfide Enhances Chemosensitivity of Human Gastric Cancer Cells to Docetaxel Through Attenuating NF-κB Activation.
Topics: Adult; Aged; Allyl Compounds; Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Docetaxel; Drug Resistance, Neoplasm; Drug Synergism; Epigenesis, Genetic; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Male; Metallothionein; Mice, Nude; Middle Aged; NF-kappa B; Stomach Neoplasms; Sulfides; Taxoids; Transcriptional Activation; Up-Regulation; Xenograft Model Antitumor Assays; Young Adult | 2016 |